Biopharma

Twelfth Industry Standing Group (ISG) meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 28 March 2025, 09:00 (CET) to 28 March 2025, 14:00 (CET)

Twelfth Industry Standing Group (ISG) meeting, Online, ...

Feb 9, 2025 0

Twelfth Industry Standing Group (ISG) meeting, Online, European Medicines Agency...

Human medicines European public assessment report (EPAR): Zomarist, vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Zomarist, vildagliptin...

Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 20/12/2021, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Va...

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 June 2025, 10:00 (CEST) to 26 June 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025 0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Pro...

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – May 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 21 May 2025, 10:00 (CEST) to 21 May 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025 0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Pro...

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – April 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 29 April 2025, 10:00 (CEST) to 29 April 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025 0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Pro...

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – April 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 1 April 2025, 10:00 (CEST) to 1 April 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025 0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Pro...

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – February 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 February 2025, 10:00 (CET) to 26 February 2025, 12:00 (CET)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025 0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Pro...

Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) meetings

Executive Steering Group on Shortages and Safety of Med...

Feb 9, 2025 0

Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) me...

Human medicines European public assessment report (EPAR): Penbraya, Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed), Date of authorisation: 14/11/2024, Status: Withdrawn

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Penbraya, Meningococca...

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – December 2025, European Medicines Agency, Amsterdam, the Netherlands, from 17 December 2025, 10:00 (CET) to 17 December 2025, 12:00 (CET)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025 0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Pro...

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 November 2025, 10:00 (CET) to 19 November 2025, 12:00 (CET)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025 0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Pro...

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – October 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 October 2025, 10:00 (CEST) to 22 October 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025 0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Pro...

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – July 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 July 2025, 10:00 (CEST) to 23 July 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025 0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Pro...

EMEA-001434-PIP01-13-M03

EMEA-001434-PIP01-13-M03

Feb 9, 2025 0

EMEA-001434-PIP01-13-M03

List of European Union reference dates (EURD) and frequ...

Feb 9, 2025 0

List of European Union reference dates (EURD) and frequency of submission of per...

Human medicines European public assessment report (EPAR): Lantus, insulin glargine, Date of authorisation: 09/06/2000, Revision: 42, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Lantus, insulin glargi...

Human medicines European public assessment report (EPAR): Apidra, insulin glulisine, Date of authorisation: 27/09/2004, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Apidra, insulin glulis...

Human medicines European public assessment report (EPAR): Wyost, denosumab, Date of authorisation: 17/05/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Wyost, denosumab, Date...

Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutini...

Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation: 15/09/2023, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab...

Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Icandra (previously Vi...

Questions and answers on implementation of the medical ...

Feb 9, 2025 0

Questions and answers on implementation of the medical devices and in vitro diag...

PSUSA/00002229/202404

PSUSA/00002229/202404

Feb 9, 2025 0

PSUSA/00002229/202404

60
61
62
63
64

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.